Application of 3D Printing in Laparoscopic Surgery of Liver Tumors
NCT ID: NCT03744624
Last Updated: 2022-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
85 participants
INTERVENTIONAL
2017-04-28
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas
NCT03382327
Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors
NCT06526754
National Polish Registry of Minimally Invasive Liver Surgery
NCT05516394
Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver
NCT01474694
Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma
NCT06496113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Accuracy of 3D printed liver models compared to computed tomography and standard surface or volume rendering
2. Whether 3D printed utilized in planning surgery affects the decision making regarding the surgical plan
3. Whether 3D printed models utilized in planning and navigating laparoscopic resections affect perioperative outcomes
Methodology of developing 3D models is described elsewhere. Printed models will be delivered to surgical team at least 5 days prior to the resection. Surgery will be performed in both arms according to the department's procedures and surgical oncology guidelines.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With 3D Model
Patients in this arm will undergo laparoscopic liver resection with prior planning utilizing both 3D printed model and computed tomography (or/and magnetic resonance imaging)
Laparoscopic liver resection
Laparoscopic liver resection for oncological purposes
3D printing model
Use of 3D printed liver model in decision-making: preoperative planning and intraoperative guidance.
Without 3D Model
Patients in this arm will undergo laparoscopic liver resection with prior planning utilizing only standard medical imaging computed tomography (or/and magnetic resonance imaging) without development of 3D printed model
Laparoscopic liver resection
Laparoscopic liver resection for oncological purposes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic liver resection
Laparoscopic liver resection for oncological purposes
3D printing model
Use of 3D printed liver model in decision-making: preoperative planning and intraoperative guidance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient qualified to undergo liver tumor resection (either primary of metastatic; both benign and malignant lesions)
* Quality of imaging (CT or MRI or PET (positron emission tomography)/CT) satisfactory to develop 3D models
* Laparoscopic approach
* Informed consent
Exclusion Criteria
* Technical limitations to model development
* No informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Witowski
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Department of General Surgery Jagiellonian Univeristy Medical College
Krakow, Lesser Poland Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Witowski JS, Pedziwiatr M, Major P, Budzynski A. Cost-effective, personalized, 3D-printed liver model for preoperative planning before laparoscopic liver hemihepatectomy for colorectal cancer metastases. Int J Comput Assist Radiol Surg. 2017 Dec;12(12):2047-2054. doi: 10.1007/s11548-017-1527-3. Epub 2017 Jan 31.
Witowski J, Wake N, Grochowska A, Sun Z, Budzynski A, Major P, Popiela TJ, Pedziwiatr M. Investigating accuracy of 3D printed liver models with computed tomography. Quant Imaging Med Surg. 2019 Jan;9(1):43-52. doi: 10.21037/qims.2018.09.16.
Witowski J, Budzynski A, Grochowska A, Ballard DH, Major P, Rubinkiewicz M, Zlahoda-Huzior A, Popiela TJ, Wierdak M, Pedziwiatr M. Decision-making based on 3D printed models in laparoscopic liver resections with intraoperative ultrasound: a prospective observational study. Eur Radiol. 2020 Mar;30(3):1306-1312. doi: 10.1007/s00330-019-06511-2. Epub 2019 Nov 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0054/DIA/2018/47
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
122.6120.81.2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.